A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol.
Moritoyo T, Nishimura N, Hasegawa K, Ishii S, Kirihara K, Takata M, Svensson AK, Umeda-Kameyama Y, Kawarasaki S, Ihara R, Sakanaka C, Wakabayashi Y, Niizuma K, Tominaga T, Yamazaki T, Hasumi K.
Moritoyo T, et al. Among authors: hasumi k.
Br J Clin Pharmacol. 2023 Jun;89(6):1809-1819. doi: 10.1111/bcp.15651. Epub 2023 Jan 11.
Br J Clin Pharmacol. 2023.
PMID: 36562925
Clinical Trial.